Catalyst Wire Dossier Catalyst Wire Dossier

LYR-210

· Lyra Therapeutics
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for LYR-210, covering 2023-06-06 to 2026-02-19. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults (ENLIGHTEN 2) [Phase 3]

See pricing